Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Stevanato Group S P A currently manages 1 pending office actions. This action is being reviewed by 1 distinct examiners, creating a focused prosecution environment for the company. The data shows 0 distinct art units, which could mean the 1 pending office actions are in a preliminary stage or fall outside typical art unit classifications. This 0 distinct art units figure suggests a unique technological profile for the current filing.
PATEL, SHEFALI DILIP is the busiest examiner for this portfolio, currently handling 1 busiest examiner pending office action. Because the portfolio only contains 1 distinct examiners, PATEL, SHEFALI DILIP is the only official currently reviewing the 1 pending office actions. The 0 distinct art units associated with this portfolio suggest that there is no broader art unit context to inform the prosecution. Practitioners should prioritize the specific feedback from PATEL, SHEFALI DILIP to advance the 1 busiest examiner pending action. The individual examiner's interpretation will be the primary factor in the outcome of the 1 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, SHEFALI DILIP | 1 | 58.0% | +27.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694903 | METHOD OF MANUFACTURING A MEDICAL INJECTION DEVICE AND MEDICAL INJECTION DEVICE THUS OBTAINED | PATEL, SHEFALI DILIP | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694903 | METHOD OF MANUFACTURING A MEDICAL INJECTION DEVICE AND MEDICAL INJECTION DEVICE THUS OBTAINED | PATEL, SHEFALI DILIP | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694903 | METHOD OF MANUFACTURING A MEDICAL INJECTION DEVICE AND MEDICAL INJECTION DEVICE THUS OBTAINED | PATEL, SHEFALI DILIP | — | §103§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial